MVP acquires Avita Medical respiratory business

Company News

Medical Developments International Limited (ASX:MVP) has announced that it has signed an agreement to acquire the respiratory business of Avita Medical.
 
Avita’s respiratory business includes the leading brand of asthma space chambers in the Australian pharmacy and hospital markets. 
 
The total consideration for the acquisition is about $2.64 million, comprising cash and shares.
 
The transaction is expected to be completed by early February next year. 
 
Medical Developments International reported a net profit of $1.53 million at 30 June 2015. 

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?